Wednesday, January 18, 2017

BRIEF-FDA grants fast track designation for aTyr's Resolaris

* Fda grants fast track designation for aTyr's Resolaris to

treat limb girdle muscular dystrophy 2b and removes partial

clinical hold for Resolaris

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)